Hubbry Logo
DEETDEETMain
Open search
DEET
Community hub
DEET
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
DEET
DEET
from Wikipedia
Not found
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
DEET, chemically known as N,N-diethyl-meta-toluamide, is a synthetic that functions as the in numerous commercial formulations, primarily used to deter biting arthropods such as mosquitoes, ticks, fleas, and chiggers from humans and animals without killing them. Developed in 1946 by the for the U.S. Army to protect soldiers in insect-heavy environments during and after , DEET was first registered for civilian use by the Environmental Protection Agency (EPA) in 1957 and has since become the most common and effective repellent worldwide, with over 120 EPA-registered products containing it as of 2025. DEET is typically formulated as a colorless to pale yellow liquid or in lotions, sprays, and wipes, with concentrations ranging from 5% to 100%, though efficacy plateaus around 50% for most applications; lower concentrations (10-30%) provide 2-6 hours of against mosquitoes, while higher ones extend this to 8-10 hours or more depending on environmental factors like and insect species. Its mechanism involves interfering with insects' olfactory receptors, masking scents or directly repelling them upon contact, making it a broad-spectrum option effective against a wide range of pests that transmit diseases like , Zika, , and . When applied as directed on or , DEET is considered safe and effective by regulatory bodies including the EPA, Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO), with minimal absorption through intact and low overall in humans. It is approved for use on children of any age (though concentrations not exceeding 30% are recommended for infants and young children) and during or , showing no increased risk of adverse birth outcomes in studies of exposed populations. Potential side effects are rare and usually limited to mild skin irritation such as redness, itching, rash, or a burning/stinging sensation from direct contact, overuse, extended periods, application to sensitive areas, or excessive use, especially with concentrations like 25%; these reactions are uncommon and typically resolve quickly after washing off the product, with fewer than 50 confirmed cases of severe reported globally since its introduction despite billions of applications. Environmentally, DEET degrades relatively quickly in soil and water under sunlight but can persist in at low levels, prompting ongoing monitoring by agencies like the EPA.

Chemistry

Structure and properties

DEET, chemically designated as N,N-diethyl-3-methylbenzamide, possesses the molecular formula \ce{C12H17NO}. Its IUPAC name reflects the core substituted with a at the meta position and diethyl groups on the nitrogen atom. The compound is an derivative of meta-toluic (3-methylbenzoic ), in which the hydroxyl group of the is replaced by a diethylamino moiety, resulting in a tertiary structure. This configuration contributes to its stability and characteristic properties as an organic liquid. DEET manifests as a colorless to pale yellow oily liquid with a faint, characteristic odor. It has a of 0.998 g/cm³ at 20°C and a of -45°C. The is 284–285°C at or approximately 111°C at 1 mmHg reduced . Its in is low, approximately 1 g/100 mL at 25°C, while it is miscible with many organic solvents such as and . The octanol-water partition coefficient (log K_{ow}) ranges from 1.87 to 2.85, indicating moderate that influences its partitioning between aqueous and environments. Spectroscopic characterization aids in its identification. In infrared (IR) spectroscopy, DEET exhibits a characteristic amide carbonyl stretch at approximately 1650 cm^{-1}, along with C-H stretching bands around 2980–3040 cm^{-1} for aromatic and aliphatic hydrogens. Nuclear magnetic resonance (NMR) data include ^1H NMR signals for the aromatic protons (7.0–7.4 ppm, multiplet), the methyl group on the benzene ring (2.3 ppm, singlet), and the diethyl methylene and methyl groups (1.1–1.3 ppm and 3.2–3.4 ppm, respectively). These features confirm the structural integrity of the compound.

Synthesis

DEET, chemically N,N-diethyl-3-methylbenzamide, is primarily synthesized through a two-step process starting from m-toluic acid (3-methylbenzoic acid). In the first step, m-toluic acid reacts with (SOCl₂) to form the corresponding acid chloride, 3-methylbenzoyl chloride, typically under conditions with a solvent like or to facilitate the chlorination while minimizing side reactions. This intermediate then undergoes nucleophilic acyl substitution with (HN(CH₂CH₃)₂) in the second step, yielding DEET as the product after neutralization and purification, often achieving yields above 80% in laboratory settings. Alternative synthetic routes to DEET include direct amide coupling methods that bypass the acid chloride intermediate, such as the use of coupling agents like dicyclohexylcarbodiimide (DCC) or carbonyldiimidazole (CDI) to react m-toluic acid directly with , which reduces the risk of handling corrosive reagents and improves . Catalytic approaches, such as palladium-catalyzed amidation of aryl halides derived from m-toluidine precursors, have also been explored for more sustainable synthesis, though these are less common in commercial production due to cost considerations. Esterification variants, involving the formation of a from m-toluic acid followed by aminolysis with , provide another pathway but often require harsher conditions and lower selectivity compared to the standard route. Industrial production of DEET emphasizes scalable, cost-effective processes based on the primary acid chloride route, with large-scale reactors handling thionyl chloride reactions under controlled temperatures to manage exothermic byproducts like HCl and SO₂ gases. Scale-up considerations include efficient solvent recovery, such as distillation of toluene, and the use of continuous flow systems to enhance safety and throughput, enabling annual production capacities in the thousands of metric tons for global repellent markets. The final product is purified via distillation or crystallization to meet purity standards exceeding 95%, as required for insect repellent formulations to ensure efficacy and regulatory compliance under standards like those from the EPA. The synthesis of DEET was developed in the aftermath of , building on earlier chemistry research at the U.S. Department of Agriculture's Division, where initial laboratory preparations in the late 1940s optimized the m-toluic acid route for rapid production to meet military and civilian demands for . Post-war advancements included refinements in 1950s patents that improved yield and purity through better reaction controls, establishing the method as the industrial standard by the 1960s.

Uses and effectiveness

Applications

DEET is primarily used as a topical insect repellent applied directly to the skin of humans and animals to protect against biting pests, including mosquitoes, ticks, fleas, flies, and chiggers. It is effective in outdoor settings such as , , and travel to regions with high insect activity, where it helps prevent bites from disease-carrying arthropods. DEET is available in various formulations, including creams, lotions, sprays, and aerosols, with concentrations ranging from 5% to 100% depending on the intended duration of and user needs. Lower concentrations (around 5-10%) are suitable for short-term use, while higher ones (up to 50% or more) provide longer-lasting repellency. Beyond direct skin application, DEET can be applied to to extend , though it may damage certain synthetic fabrics or plastics at high concentrations. For gear such as tents and nets, treatment is recommended instead. It has limited veterinary applications for repelling on pets and , and is not commonly used in due to its targeted role in personal rather than crop treatment. Globally, DEET is used by an estimated 200 million people annually, playing a crucial role in preventing mosquito-borne diseases such as and transmission in endemic areas. Its widespread adoption underscores its status as a cornerstone of strategies recommended by health authorities.

Concentrations and efficacy

DEET demonstrates varying levels of repellency depending on concentration and target pest. Against and mosquitoes, formulations containing 30% DEET typically provide protection for up to 12 hours under controlled conditions, while for ticks, efficacy lasts up to 8 hours at similar concentrations. The duration of protection increases with higher DEET concentrations, but benefits plateau beyond a certain point. A 10% concentration offers 2–3 hours of repellency against mosquitoes and ticks, suitable for short exposures. Concentrations of 50–100% extend protection to 10–12 hours for mosquitoes and 8–10 hours for ticks, though studies indicate no significant additional benefit beyond 50% for most users due to saturation of the repellent effect. The Centers for Disease Control and Prevention (CDC) recommends DEET concentrations of 20% or higher for reliable protection in high-risk areas; the (WHO) recommends the use of repellents containing DEET, based on extensive field trials demonstrating 70–100% reduction in bites from mosquitoes and ticks. For instance, trials with 20–30% DEET have shown 86–97% repellency against blacklegged ticks and species in outdoor settings. Efficacy can be influenced by environmental factors such as , , and , which accelerate and reduce duration in hot, humid, or windy conditions. Insect species variations also play a role, though reports of significant resistance to DEET remain minimal across major pests like mosquitoes and ticks.

Health effects

Contraindications

DEET is not recommended for application to infants under 2 months of age due to potential differences in skin absorption and immature metabolic pathways, as advised by the (AAP); although the U.S. Environmental Protection Agency (EPA) approves DEET for use without age restrictions. Instead, protective measures such as mosquito netting are preferred for this age group. Use of DEET should be avoided on open wounds, cuts, or irritated skin, as it may increase absorption and risk of irritation, according to guidelines from the U.S. Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention (CDC). For pregnant and women, DEET is considered safe when used as directed, but the lowest effective concentration is recommended to minimize exposure, per assessments from the CDC and MotherToBaby. In children over 2 months, the AAP advises against using products with more than 30% DEET concentration to reduce potential risks while maintaining efficacy. Hypersensitivity reactions to DEET are rare but can occur in individuals with allergies to amides or related toluamides, potentially manifesting as contact urticaria or , as documented in case reports. Individuals with known allergies should consult a healthcare provider before use.

Adverse effects

DEET is generally well-tolerated when used as directed, but common adverse effects from topical application include skin , rash, and itching at the site of application, with a low incidence reported in human studies. For concentrations such as 25%, some individuals may experience mild skin irritation such as redness, itching, rash, or a burning/stinging sensation, especially with extended periods of use, application to sensitive areas, or excessive application; these reactions are uncommon and usually resolve quickly after washing off the product. These dermal reactions are typically mild and transient, often associated with higher concentrations (above 50%) or repeated exposure, and resolve without intervention. Severe reactions such as significant pain, blistering, or substantial discomfort are rare and more likely with concentrations greater than 50%, prolonged heavy use, or in sensitive individuals. Rare adverse effects may occur if DEET contacts the eyes, leading to , , or lacrimation. In extreme cases, such as excessive application or , neurological symptoms including seizures have been reported, though the incidence is extremely low at approximately 1 per 100 million users. Long-term topical use of DEET shows no evidence of chronic health issues, as skin absorption is limited to about 5-8% of the applied dose under normal conditions. Adverse incidents related to DEET can be reported through the FDA's MedWatch program, which tracks potential safety concerns from consumer products.

Carcinogenicity

DEET has been classified by the U.S. Environmental Protection Agency (EPA) as a Group D substance, not classifiable as to its human carcinogenicity, due to inadequate evidence in humans and animals. The International Agency for Research on Cancer (IARC) has not evaluated or classified DEET with respect to its carcinogenicity to humans. In chronic carcinogenicity studies, DEET administered in the diet to rats for two years at doses up to 100 mg/kg/day in males and 400 mg/kg/day in females produced no treatment-related increases in tumor incidence. Similarly, dietary exposure to DEET in mice for 18 months at doses up to 1,000 mg/kg/day in both sexes did not result in any significant elevation of tumors compared to controls. Epidemiological data on DEET exposure and cancer risk in humans are limited. One case-control study suggested an increased risk of (OR 1.7) associated with prolonged use of insect repellents mostly containing DEET, though it did not adjust for potential confounders and has not been replicated; comprehensive reviews conclude that DEET is unlikely to pose a carcinogenic risk. Long-term cohorts of frequent DEET users, such as , have shown no elevated cancer rates attributable to exposure. DEET and its primary metabolites exhibit no genotoxic potential, testing negative in the Ames bacterial reverse mutation assay across multiple strains with and without metabolic activation. Additionally, DEET showed no evidence of inducing chromosomal aberrations in cells or sister exchanges in human lymphocytes.

Overdose

DEET exhibits moderate , with an oral LD50 of approximately 2 g/kg in rats, indicating that it requires relatively high doses to cause lethality in animal models. In these studies, toxic effects manifest primarily as neurological symptoms, including , tremors, and seizures, which are dose-dependent and reversible in surviving animals at sublethal exposures. Human overdoses of DEET most commonly occur via accidental ingestion, such as swallowing insect repellent products, while dermal overdoses are rare due to limited skin absorption rates of 5-30% depending on formulation and application site. Symptoms of acute overdose in humans mirror those observed in animals, encompassing central nervous system effects like ataxia, tremors, seizures, agitation, and in severe cases, coma or respiratory depression; gastrointestinal symptoms such as nausea and vomiting may also precede neurological involvement. Treatment for DEET overdose is primarily supportive, focusing on , control, and . For , administration of activated charcoal may be considered if presentation is prompt, though its efficacy is limited by rapid absorption; benzodiazepines are recommended for managing . In cases of dermal exposure, thorough washing of the skin is advised to minimize further absorption. Case reports of DEET overdose are infrequent, with most involving children due to accidental massive , and fatalities are rare but have been documented, primarily from intentional or large-volume consumption leading to and multi-organ failure. For instance, among reported pediatric cases, a small number have resulted in death despite aggressive intervention, underscoring the vulnerability of young children to high-dose exposures.

Detection in body fluids

DEET and its metabolites can be detected in human and plasma primarily through gas chromatography-mass spectrometry (GC-MS), which allows for sensitive quantification following extraction procedures such as one-step solvent extraction with tert-butylmethylether. This technique is widely used due to its high specificity and ability to distinguish DEET from structurally similar compounds. Limits of detection (LOD) for DEET in urine typically reach 0.1 µg/L, with recovery rates exceeding 98%, enabling reliable measurement even at low exposure levels. In plasma, GC-MS methods achieve LODs ranging from 20 to 100 ng/mL, supporting in clinical and research settings. The primary metabolite of DEET in humans is N,N-diethyl-m-hydroxymethylbenzamide (also referred to as DHMB), formed through oxidative primarily in the liver. This , along with others like 3-(diethylcarbamoyl)benzoic acid (DCBA), predominates in urinary excretion and serves as a for recent exposure. The elimination of DEET in plasma is approximately 2.5 hours, though it can range from 2 to 5 hours depending on the route of exposure and individual factors, facilitating its rapid clearance from the body. Following oral , such as in accidental or intentional overdose scenarios, DEET reaches peak plasma concentrations within 1 to 2 hours, reflecting rapid absorption from the . Urinary excretion accounts for 50–70% of the , primarily as metabolites like DHMB and DCBA, with the majority eliminated within 24 hours. This pharmacokinetic profile supports studies assessing exposure levels in populations using DEET-based repellents. In forensic contexts, detection of DEET in body fluids plays a key role in investigating overdose cases, where elevated concentrations in or —often exceeding 8 mg/dL in fatal ingestions—confirm ingestion as a contributing factor to . Additionally, routine monitoring of DEET and its metabolites in and aids occupational and environmental exposure assessments, particularly for individuals in high-risk professions like .

Interactions and compatibility

Drug interactions

DEET exhibits minimal pharmacokinetic interactions with other pharmaceuticals due to its limited systemic absorption following topical application and low potential for () enzyme inhibition in humans. Studies indicate that DEET is primarily metabolized by enzymes, such as and , into metabolites like N,N-diethyl-m-hydroxymethylbenzamide, but it does not significantly inhibit these enzymes or alter the metabolism of common . Consequently, no clinically significant interactions have been reported with common pharmaceuticals. When applied topically with , DEET's skin absorption can increase, potentially enhancing its , though this does not typically lead to adverse systemic effects at recommended concentrations. This interaction arises because certain formulations may alter skin permeability, but using separate products and applying first, followed by DEET after 15-30 minutes, minimizes enhanced absorption while maintaining efficacy. DEET should also be used cautiously with other topical products, and applications spaced by at least 30 minutes are recommended to avoid unintended synergies or incompatibilities. Additionally, DEET can interact with certain plastics, leading to material degradation, though this is addressed in detail under damage to materials. Preclinical studies, including and animal models, suggest potential synergistic when DEET is combined with or insecticides or other cholinesterase inhibitors, possibly due to DEET's mild inhibition of in mammalian systems. For instance, DEET has been shown to potentiate effects on cholinesterases, with theoretical implications for enhanced with drugs that lower thresholds (e.g., bupropion), though no widespread clinical confirms this in humans. Such interactions are infrequent and primarily observed in high-exposure scenarios, such as occupational use; health authorities advise avoiding simultaneous use of DEET with these compounds when possible.

Damage to materials

DEET, a common , acts as a and that can degrade certain synthetic materials upon contact. It readily dissolves , commonly known as , by breaking down its structure, which can lead to complete disintegration in cases of prolonged exposure. Additionally, DEET weakens or damages other plastics such as (PVC), , and vinyl, as well as elastic materials like rubber; users are advised to avoid applying it near eyeglass frames, watch crystals, contact lenses, or other plastic components to prevent cracking, softening, or melting. Regarding fabrics, DEET can discolor or degrade synthetic materials like , Lycra, , and , particularly with repeated or high-concentration exposure, potentially causing weakening or staining. In contrast, it is generally safe for short-term contact with natural fibers such as and , or durable synthetics like , though extended exposure may still pose risks to finishes or dyes. To mitigate damage, DEET should be stored and applied using compatible containers made from (HDPE), which resists degradation due to its chemical resistance. After use on or gear, items should be rinsed thoroughly with and water to remove residues and prevent long-term effects on susceptible materials.

Environmental impact

Ecological effects

DEET demonstrates low acute toxicity to terrestrial non-target organisms such as birds and bees. For birds, the oral LD50 is 1375 mg/kg, classifying it as slightly toxic but posing negligible risk under typical environmental exposure levels. Similarly, DEET exhibits low toxicity to bees and other pollinators, with no significant adverse effects reported in ecological assessments due to its repellent rather than insecticidal mode of action. In aquatic environments, DEET shows moderate sensitivity among invertebrates, with an EC50 of 75 mg/L for in 48-hour acute toxicity tests, indicating slight overall toxicity to this species. The U.S. Agency (EPA) has concluded that DEET poses no risks of concern to aquatic life based on reviewed toxicity data and estimated environmental concentrations. Concerns regarding runoff arise from DEET's detection in effluents at low concentrations, typically ranging from 1.4 to 23 ng/L in surface waters. However, bioaccumulation potential remains low, with bioconcentration factors (BCF) below 10, preventing significant buildup in tissues. Field studies and EPA assessments confirm minimal disruption to communities and , as environmental levels stay well below thresholds for adverse effects on non-target species.

Persistence and degradation

DEET demonstrates moderate environmental persistence, degrading relatively rapidly in most compartments through biotic and abiotic processes. In aerobic soils, its ranges from days to weeks, reflecting moderate to rapid microbial breakdown. Under anaerobic conditions, degradation is slower but still occurs without accumulation of long-lived residues. In surface waters, direct photolysis under accelerates , with a reported half-life of approximately 5 days in illuminated river water, compared to 15 days in the dark. The main degradation pathway for DEET in the environment involves microbial of its bond, primarily by such as , producing m-toluic acid (3-methylbenzoic acid) and as initial products. These metabolites are further mineralized through subsequent oxidation and dealkylation steps, with no persistent transformation products identified that resist breakdown. Abiotic processes, including reactions in air ( ~15 hours) and in , contribute to overall dissipation but are secondary to biotic pathways in soils and sediments. DEET's environmental mobility is influenced by its high aqueous solubility (>1 g/L at 20°C), which promotes leaching into following surface application or runoff. However, its soil organic carbon-water (Koc) of approximately 300 indicates moderate adsorption to organic matter, limiting extreme mobility and favoring retention in upper layers under typical conditions. Monitoring studies reveal widespread but low-level presence of DEET in global surface waters, with detections typically below 1 µg/L across diverse regions including , , and ; higher concentrations up to 24 µg/L occur near wastewater discharges but dilute rapidly. No evidence of has been observed in aquatic or terrestrial food webs, consistent with its rapid degradation and moderate (log Kow ~2.1).

Mechanism of action

Biochemical interactions

DEET is detected by specific olfactory receptor neurons (ORNs) in antennae, such as in , where it elicits dose-dependent responses with a threshold around 1 μg, triggering avoidance without interfering with the detection of host odors like or . Electrophysiological studies have identified DEET-sensitive ORNs that respond to the compound, contributing to repellency through direct sensory activation rather than attenuation of host attractant responses. Structural analyses using cryo-electron microscopy confirm that DEET binds to the ligand-binding pocket in the of ORs, such as MhOR5, acting as an that induces conformational changes to open ion channels and activate the receptors. In addition to peripheral olfactory interference, DEET may modulate receptors in , with evidence suggesting interactions at octopaminergic synapses that contribute to neuroexcitation at higher concentrations, though direct modulation remains unconfirmed in arthropods. Unlike traditional insecticides, DEET exerts no significant systemic insecticidal action at typical repellent concentrations; it functions solely as a spatial or contact repellent by disrupting sensory perception rather than causing through neurotoxic overload. High-dose exposure can induce in insects via indirect neuronal effects, but standard use avoids such thresholds. employing intracellular recordings from neurons, akin to patch-clamp techniques, has revealed that DEET elevates firing rates in octopamine-sensitive cells, leading to hyperactivity and hyperexcitation, which may underlie its repellent efficacy at the physiological level. These findings highlight DEET's targeted disruption of sensory and modulatory pathways without broad-spectrum killing.

Insect behavioral effects

DEET primarily achieves repellency through two behavioral modes: spatial avoidance and contact irritancy. In spatial repellency, detect DEET vapors from a distance via their olfactory receptors, leading to oriented avoidance of treated areas before making contact; this is particularly evident in flying like mosquitoes, where the compound acts as a repellent that avoid. Contact irritancy, on the other hand, activates escape responses upon direct exposure, such as rapid flight takeoff or cessation of probing in blood-feeders, as the irritant stimulates non-olfactory sensory neurons on the legs or mouthparts. These modes often act synergistically, enhancing overall deterrence by disrupting host-seeking behaviors at multiple stages. The behavioral effects of DEET exhibit species-specific variations, with stronger avoidance responses in blood-feeding arthropods such as mosquitoes ( and ) and ticks compared to non-biting crawling pests like ants or cockroaches. In mosquitoes, DEET elicits pronounced spatial deterrence in species like and , reducing attraction to human odors, whereas it functions mainly as a contact irritant in Anopheles coluzzii without significant olfactory repulsion. For crawling pests like bed bugs, DEET combines both modes to repel host-seeking individuals, though efficacy may require higher concentrations than in flying blood-feeders. This differential responsiveness underscores DEET's targeted impact on hematophagous insects, where it interferes more effectively with feeding-related behaviors. Laboratory assays, such as Y-tube olfactometers, quantify these effects by measuring choice between DEET-treated and control arms; studies show 80–95% deterrence in mosquitoes, with attraction to treated sides dropping to 5–20% of controls when paired with lures. In arm-in-cage tests, DEET activates flight responses in over 90% of landing mosquitoes within seconds, confirming irritancy as a rapid behavioral disruptor. These assays demonstrate DEET's ability to alter orientation and rates without , focusing on non-contact evasion. The persistence of DEET's behavioral effects is limited by its volatility, which causes gradual and reduces vapor concentration over time, typically requiring reapplication every 2–12 hours depending on . External factors like disperse airborne DEET, shortening spatial repellency range, while sweat and accelerate dermal wash-off, diminishing contact protection by up to 50% in humid conditions. These dynamics highlight the need for environmental considerations in maintaining avoidance behaviors.

History and regulation

Development and history

DEET was developed in 1946 by USDA entomologist Samuel Gertler at laboratories in the United States as part of efforts to create effective insect repellents for the U.S. Army, driven by the need to protect troops from mosquito-borne diseases encountered during and after World War II. The compound, chemically known as N,N-diethyl-meta-toluamide, emerged from systematic screening of thousands of potential chemicals to identify one that could provide prolonged protection against biting insects in tropical environments. Initial field trials in the early 1950s, including tests conducted by the USDA in , in 1952, demonstrated DEET's superior efficacy compared to existing repellents, which typically lasted only about two hours. These evaluations confirmed that DEET could repel mosquitoes and other pests for up to 10 hours, leading to its rapid adoption by the . By , DEET was registered for civilian use under federal pesticide regulations, marking the introduction of commercial products such as the Repel , which helped popularize it among the general public. DEET reached peak military application during the era in the and 1970s, where it was distributed to U.S. troops as a liquid formulation nicknamed "" to counter the intense insect threats in environments that spread diseases like . Its reliability in these conditions solidified DEET's reputation as the gold standard for insect repellents, with over 8 billion applications worldwide by the late . In recent years, particularly post-2020, DEET formulations have undergone reformulations by manufacturers to address concerns over odor and environmental persistence, incorporating carriers and additives that enhance user acceptability while maintaining efficacy. These updates reflect ongoing efforts to balance DEET's proven protective benefits with improved safety profiles for broader adoption in diverse settings.

Regulatory approvals

In the United States, the Environmental Protection Agency (EPA) has classified DEET as a low-risk following its Reregistration Eligibility Decision in 1998, with an interim registration review decision issued in September 2014 that required no additional data or changes to existing registrations. The EPA's registration review for DEET, initiated under the ongoing process, has not identified risks of concern to human health, non-target species, or the environment as of November 2025, with previous decisions in 1998 and an interim review in 2014 requiring no changes; the final decision remains pending completion of the Screening Program, with no new mitigation measures implemented to date. DEET products are approved for concentrations up to 100%, with no limits on percentage for use on children, as data show no differential effects by age when applied according to label instructions. Internationally, DEET is approved under the European Union's Biocidal Products Regulation (EU) No 528/2012, having been included in Annex I of the predecessor Biocidal Products Directive 98/8/EC following evaluation under Regulation (EC) No 1451/2007. The extended DEET's approval as an active substance until January 31, 2027, to allow completion of ongoing reviews without imposing new restrictions. The (WHO) recommends DEET as one of three active ingredients for topical repellents in guidelines, emphasizing its role in personal protection against and other diseases, though specific products are not prequalified under WHO's program. Labeling requirements for DEET products in the U.S. mandate statements such as "Read and follow all directions and precautions on this product label" and warnings against applying to hands or near food for children, with the EPA confirming compatibility for simultaneous use with without reduced efficacy or increased risk when both are applied as directed. In the , labels must include child safety precautions aligned with biocidal product authorizations, such as avoiding use on infants under specified ages and noting interactions to prevent over-application. As of 2025, regulatory reviews by the EPA and authorities have confirmed DEET's continued approval without new restrictions, even as alternatives like picaridin gain popularity; these do not supersede DEET's established status for broad-spectrum insect repellency.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.